What is the CAMEO organoid sensor? Researchers have created a low-cost, carbon nanotube-based microelectrode array to monitor ...
Researchers have demonstrated a new class of low-cost, scalable sensors that can be used to monitor electrical activity in ...
Affected populations: The disorder is believed to affect somewhere between 1 in 12,000 and 1 in 24,000 people, although these figures may be underestimated. Many cases of Angelman syndrome can go ...
For the first time, the Brazilian Football Confederation (CBF) joins Angelman Brasil in a national awareness campaign about Angelman Syndrome, a rare and still little-known genetic condition. The ...
NOVATO, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (RARE), today announced that the first patient has been dosed in the pivotal Phase 3 Aspire study (NCT06617429) ...
The Pinball Lounge at 78th Street Sudios offers an ideal setting for this unique fundraiser. The event runs from 4-6 pm, providing families with an accessible Sunday afternoon activity. True to its ...
Company expects to complete Phase 3 Aspire study in the second half of 2026 Aurora study of GTX-102 in additional ages and genotypes on track to initiate in the second half of 2025 “The accelerated ...
Researchers have demonstrated a new class of low-cost, scalable sensors that can be used to monitor electrical activity in ...
Ultragenyx Pharmaceutical Inc. announced the dosing of the first patient in its Phase 3 Aspire study, which is investigating the safety and efficacy of GTX-102, an investigational antisense ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results